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Introduction
Acute Lung Injury (ALI) and Acute Respiratory Distress
Syndrome (ARDS) are characterized by a promptly release
of proinflammatory mediators that downregulate natural
anticoagulant mechanisms, initiate the coagulation system,
impair fibrinolysis and produce the rupture of the
endothelial and epithelial monolayer [1]. Inflammation of
ALI/ARDS is initiated and strongly regulated by proin-
flammatory activation of macrophages, which lead to the
recruitment of other inflammatory cells, producing alveo-
lar cells injury, propagating the coagulant response and
promoting the injury. Currently there is no effective treat-
ment for this disease. Previous studies have presented the
beneficial effect of anticoagulants, not only for their antic-
oagulation activity but also for their antiinflammatory
action [2],[3].
Objectives
To evaluate the effect of the treatment with heparin in
human alveolar cells and alveolar macrophages after
induce an injury, mimicking an in-vitro ALI.
Methods
Human alveolar primary cells and alveolar macrophages
from pulmonary biopsies were isolated and seeded.
Sodium non-fractioned heparin (100 UI/ml) was adminis-
tered to the cells after the induction of an injury with a
pro-inflammatory stimulus (Cytomix: mix of TNFa, IL1b
and IFNg; 25 ng/ml or Lipopolysaccharide protein from
Escherichia coli 055 : B5; 1000 ng/ml). The effect of
heparin was assessed by the analysis of proinflammatory
markers (IL12p40, iNOS, TNFa and IL-1b) and anti-
inflammatory markers (IL10 and IL13), cell proliferation
and permeability (measuring transmembrane resistance).
Data are expressed as mean ± SEM (units are relative to
the expression of control group). Statistical analysis was
performed using One-Way-ANOVA and post-hoc
(Newman Keuls) test. Statistical significance p ≤ 0.05 is
considered.
Results
Heparin was able to modify the inflammatory response of
both cell populations, decreasing it significantly (p ≤ 0.05)
in the case of macrophages (iNOS: Control:1 ± 0.09,
Injured group:41.68 ± 4.86, Heparin group:0.54 ± 0.06.
IL12p40: Control:1 ± 0.11, Injured group:46.74 ± 4.32,
Heparin group:0.15 ± 0.009). The permeability of the
monolayer and cell proliferation of alveolar cells did not
show changes.
Conclusions
Heparin has an immunomodulatory effect in alveolar cells
and reduces inflammation in macrophages. This mechan-
ism produced by heparin could have a beneficial effect
in ALI.
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